109 related articles for article (PubMed ID: 93588)
21. The safety and efficacy of a controlled low-energy ('very-low-calorie') diet in the treatment of non-insulin-dependent diabetes and obesity.
Amatruda JM; Richeson JF; Welle SL; Brodows RG; Lockwood DH
Arch Intern Med; 1988 Apr; 148(4):873-7. PubMed ID: 3355307
[TBL] [Abstract][Full Text] [Related]
22. Insulin, growth hormone and catecholamines as regulators of energy metabolism in the course of surgery.
Aärimaa M; Syvälahti E; Viikari J; Ovaska J
Acta Chir Scand; 1978; 144(7-8):411-22. PubMed ID: 747060
[TBL] [Abstract][Full Text] [Related]
23. Clinical studies with mazindol.
Inoue S
Obes Res; 1995 Nov; 3 Suppl 4():549S-552S. PubMed ID: 8697057
[TBL] [Abstract][Full Text] [Related]
24. Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome.
De Pergola G; Giorgino F; Benigno R; Guida P; Giorgino R
Obesity (Silver Spring); 2008 Nov; 16(11):2405-11. PubMed ID: 18719673
[TBL] [Abstract][Full Text] [Related]
25. Thermogenic properties of ciclazindol and mazindol in rodents.
Wyllie MG; Fletcher A; Rothwell NJ; Stock MJ
Int J Obes; 1984; 8 Suppl 1():85-92. PubMed ID: 6534897
[TBL] [Abstract][Full Text] [Related]
26. Effects of diet, exercise and anorexigenic drugs on serum thyroid hormones.
Sonka J; Límanová Z; Zbirková A; Kratochvíl O
Endokrinologie; 1980 Dec; 76(3):351-6. PubMed ID: 7472292
[TBL] [Abstract][Full Text] [Related]
27. Hepatic and very low-density lipoprotein fatty acids in obese offspring of overfed dams.
Bouanane S; Merzouk H; Benkalfat NB; Soulimane N; Merzouk SA; Gresti J; Tessier C; Narce M
Metabolism; 2010 Dec; 59(12):1701-9. PubMed ID: 20494379
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the effect of mazindol on the metabolism and lipolysis in obese women].
Kucio C; Zahorska-Markiewicz B; Piskorska D; Semenowicz-Siuda K; Waluga M
Pol Arch Med Wewn; 1987 Mar; 77(3):73-6. PubMed ID: 3275392
[No Abstract] [Full Text] [Related]
29. Free and total triiodothyronine and thyroxine in malnourished Jamaican infants. The effect of diet on plasma levels of thyroid hormones, insulin and glucose during recovery.
Robinson HM; Betton H; Jackson AA
Hum Nutr Clin Nutr; 1985 Jul; 39(4):245-57. PubMed ID: 3930436
[TBL] [Abstract][Full Text] [Related]
30. Double-blind evaluation of mazindol in refractory obesity.
Smith RG; Innes JA; Munro JF
Br Med J; 1975 Aug; 3(5978):284. PubMed ID: 1097046
[No Abstract] [Full Text] [Related]
31. Extra-anorectic actions of mazindol.
Jonderko K; Kucio C
Isr J Med Sci; 1989 Jan; 25(1):20-4. PubMed ID: 2925353
[TBL] [Abstract][Full Text] [Related]
32. Changes in meal pattern and endogenous feeding related substances following mazindol administration.
Sakata T; Fujimoto K; Terada K; Arase K; Fukushima M
Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):11-28. PubMed ID: 6388520
[TBL] [Abstract][Full Text] [Related]
33. Double blind cross-over study of a new appetite suppressant AN 448.
Haugen HN
Eur J Clin Pharmacol; 1975; 8(1):71-4. PubMed ID: 786676
[TBL] [Abstract][Full Text] [Related]
34. Impaired glucose-induced thermogenesis in skeletal muscle in obesity. The role of the sympathoadrenal system.
Astrup A; Andersen T; Henriksen O; Christensen NJ; Bülow J; Madsen J; Quaade F
Int J Obes; 1987; 11(1):51-66. PubMed ID: 3553049
[TBL] [Abstract][Full Text] [Related]
35. [Clinical trial with a nonamphetaminic anoretic].
Campagnoli M
Rev Iber Endocrinol; 1976; 23(137):463-83. PubMed ID: 794978
[TBL] [Abstract][Full Text] [Related]
36. Weight loss through gastric banding: effects on TSH and thyroid hormones in obese subjects with normal thyroid function.
Dall'Asta C; Paganelli M; Morabito A; Vedani P; Barbieri M; Paolisso G; Folli F; Pontiroli AE
Obesity (Silver Spring); 2010 Apr; 18(4):854-7. PubMed ID: 19834461
[TBL] [Abstract][Full Text] [Related]
37. Effect of mazindol on feeding behaviour and on noradrenergic function of various parts of the rat brain.
Halmy L; Nyakas C; Walter J
Acta Physiol Acad Sci Hung; 1982; 59(4):341-7. PubMed ID: 7170986
[TBL] [Abstract][Full Text] [Related]
38. [The clinical evaluation of teronac (Mazindol) in the treatment of children with obesity. Part I. Effect of the drug on somatic patterns and exercise capacity (author's transl)].
Gołebiowska M; Chlebna-Sokoł D; Mastalska A; Zwaigzne-Raczyńska J
Przegl Lek; 1981; 38(2):311-4. PubMed ID: 7017826
[No Abstract] [Full Text] [Related]
39. Time-course changes in macronutrient metabolism induced by a nutritionally balanced low-calorie diet in obese women.
Labayen I; Diez N; Parra MD; Gónzalez A; Martínez JA
Int J Food Sci Nutr; 2004 Feb; 55(1):27-35. PubMed ID: 14630589
[TBL] [Abstract][Full Text] [Related]
40. Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity.
Enzi G; Baritussio A; Marchiori E; Crepaldi G
J Int Med Res; 1976; 4(5):305-18. PubMed ID: 1028632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
